Michael A. Panzara

CIK: 0001679039

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

LONA

LeonaBio, Inc.

Director

IMUX

IMMUNIC, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

LONA
LeonaBio, Inc.
Jun 23, 2026
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
IMUX
IMMUNIC, INC.
Apr 24, 2026
Award(A)
Stock Option
Direct
300K shares-
LONA
LeonaBio, Inc.
Apr 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
28K shares-
ATHA
Athira Pharma, Inc.
May 30, 2025
Award(A)
Stock Option (Right to Buy)
Direct
20.9K shares-

		Type	Shares	Price		Ownership
Jun 23, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
Apr 24, 2026	IMUX IMMUNIC, INC.	Award(A) Stock Option	300,000	-	-	Direct
Apr 9, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	28,000	-	-	Direct
May 30, 2025	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	20,900	-	-	Direct

1-4 of 4 transactions

About Panzara Michael A.

Panzara Michael A. (SEC CIK 0001679039) files insider reports with the SEC as Director of LeonaBio, Inc. (LONA) and Chief Medical Officer of IMMUNIC, INC. (IMUX).

Signal8 holds 5 ownership filings by Panzara Michael A. (1 Form 3, 4 Form 4), filed between Jun 3, 2025 and Jun 24, 2026. Those filings report 4 transactions, from May 30, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Panzara Michael A.'s filings is in BOTHELL, WA.

Recent filings by Panzara Michael A.

Jun 23, 2026: Grant or award of LONA derivative securities (Form 4, code A).
Apr 24, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
Apr 9, 2026: Grant or award of LONA derivative securities (Form 4, code A).
May 30, 2025: Grant or award of ATHA derivative securities (Form 4, code A).

Other insiders filing for LeonaBio, Inc. (LONA)

How to read Form 4 transaction codes